Phil Ferneau Email and Phone Number
Phil Ferneau work email
- Valid
- Valid
Phil Ferneau personal email
Phil Ferneau phone numbers
Phil Ferneau is a Co-founder/Managing Partner, Borealis Ventures at Borealis Ventures.
-
Co-Founder And Managing PartnerBorealis Ventures 2002 - PresentHanover, New Hampshire, UsEarly-stage healthcare venture capital firm, with a focus on life science platforms, digital health, and animal health opportunities. -
Board Director And InvestorCompass Therapeutics Llc 2014 - PresentBoston, Ma, UsAntibody therapeutics to treat cancer (Nasdaq: CMPX) -
Board Director And InvestorAnkyra Therapeutics Aug 2021 - PresentIntratumoral immunotherapy. -
Investor And Former Board DirectorTriveni Bio Feb 2020 - PresentWatertown, Ma, UsGenetics-informed antibody therapies for I&I disorders. -
Board Director And InvestorOvation.Io Apr 2019 - PresentCambridge, Massachusetts, UsRedefining the role of genomic laboratories in delivering better healthcare. -
Investor And Former Board DirectorT-Cypher Bio Dec 2020 - PresentOxford, GbPlatform company developing novel TCR therapies for cancer and autoimmune disease. -
Board Director And InvestorOrbit Discovery Apr 2018 - PresentOxford, GbPeptide discovery platform company spun out from the University of Oxford -
Board Observer And InvestorTeckro Dec 2018 - PresentLimerick, IeThe future of clinical research. -
InvestorAdimab 2008 - PresentLebanon, New Hampshire, UsPremier human antibody discovery and humanization. -
InvestorEvox Therapeutics Ltd 2018 - PresentOxford, England, GbTransformative exosome therapeutics. -
Adjunct ProfessorTuck School At Dartmouth College 1999 - 2023Hanover, Nh, UsAdjunct professor teaching venture capital topics and advancing Dartmouth's entrepreneurial ecosystem; formerly founding executive director of Tuck's Center for VC and private equity. -
Board Director And InvestorAvitide 2013 - Sep 2021Lebanon, New Hampshire, UsNext-gen affinity purification solutions for bioprocessing. Acquired by Repligen (Nasdaq: RGEN). -
Board Director And InvestorVets First Choice May 2010 - 2019Technology-enabled healthcare solutions to transform veterinary practice. Merged with Henry Schein Animal Health to form Covetrus, Inc. (NASDAQ: CVET).
-
Board Director And Founding InvestorAvedro, Inc. 2003 - 2019Aliso Viejo, Ca, UsWorld leader in corneal remodeling (IPO - Nasdaq: AVDR; acquired by Glaukos - GKOS). Originally spun-out from Dartmouth College. -
InvestorGlycofi 2002 - 2006UsFungal protein expression platform. Acquired by Merck & Co. for $400 million. -
Board Director And Lead InvestorM2S 2003 - 2005West Lebanon, Nh, UsMedical imaging software and web-based services for endovascular and oncology applications. Acquired by Altaris Health Partners.
Phil Ferneau Education Details
-
The Tuck School Of Business At DartmouthBusiness -
Dartmouth CollegeGovernment -
University Of Virginia School Of LawLaw
Frequently Asked Questions about Phil Ferneau
What company does Phil Ferneau work for?
Phil Ferneau works for Borealis Ventures
What is Phil Ferneau's role at the current company?
Phil Ferneau's current role is Co-founder/Managing Partner, Borealis Ventures.
What is Phil Ferneau's email address?
Phil Ferneau's email address is ph****@****res.com
What is Phil Ferneau's direct phone number?
Phil Ferneau's direct phone number is +160331*****
What schools did Phil Ferneau attend?
Phil Ferneau attended The Tuck School Of Business At Dartmouth, Dartmouth College, University Of Virginia School Of Law.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial